84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
8.1% CAGR of Human Growth Hormone Market to Reach USD 7.3 Billion by 2032, Says Market.us Research Study
23 mai 2023 10h03 HE | Market.Us
New York, May 23, 2023 (GLOBE NEWSWIRE) -- The Human Growth Hormone Market in terms of revenue was estimated to be worth USD 3.4 Bn in 2022 and is poised to reach USD 7.3 bn by 2032, growing at a...
Contrive Datum Insights_Logo.jpg
Breast Cancer Market is Expected to Grow at a CAGR of 10.43%, Reaching a Valuation of US$ 70.51 Billion from 2022-2030, Contrive Datum Insights
25 janv. 2023 00h00 HE | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The global Breast Cancer Market size was estimated at USD 31.89 Billion in 2022 and is projected to hit around USD 70.51 Billion by 2030 with a...
Reports and Data.jpeg-01
Hormone Refractory Prostate Cancer (HRPCA) Market To Reach USD 15.64 Billion By 2026| Reports And Data
19 nov. 2019 14h00 HE | Reports and Data
New york, Nov. 19, 2019 (GLOBE NEWSWIRE) -- The global hormone refractory prostate cancer (HRPCA) market is forecast to reach USD 15.64 Billion by 2026, according to a new report by Reports and...
Reports and Data.jpeg-01
Hormone Refractory Prostate Cancer (HRPCA) Market To Reach USD 15.64 Billion By 2026| Reports And Data
19 nov. 2019 14h00 HE | Reports and Data
New york, Nov. 19, 2019 (GLOBE NEWSWIRE) -- The global hormone refractory prostate cancer (HRPCA) market is forecast to reach USD 15.64 Billion by 2026, according to a new report by Reports and...
BREAST-CANCER-THERAPEUTICS-MARKET
Breast Cancer Therapeutics Market to Exhibit 10.2% CAGR, Increasing R&D Investment to Boost Growth, says Fortune Business Insights
08 juil. 2019 06h15 HE | Fortune Business Insights
Pune, July 08, 2019 (GLOBE NEWSWIRE) -- The increasing number of breast cancer cases all over the world is anticipated to boost the global Breast Cancer Therapeutics Market at promising rates, finds...